Dave Eansor was appointed the President of the Protein Sciences Segment at Bio-Techne in April 2018. Mr. Eansor also served as the Senior Vice President of the Biotech Division at Bio-Techne (2014 – 2018) and the Senior Vice President of Corporate Development at Novus Biologicals (2013 – 2014), prior to their acquisition from Bio-Techne. In addition, Mr. Eansor has extensive experience in the life science industry, including roles as President of the Bioscience Division and President of the Life Science Research business at Thermo Fisher Scientific as well as President of Cambrex Bioproducts.